Fiji's declaration of a national HIV crisis has set off a torrent of online falsehoods, blaming the Pacific nation's robust ...

GSK's ViiV Healthcare reports Cabenuva's superior viral suppression in HIV, and the company advances key acquisitions and ...

A study in Botswana finds that long-term antiretroviral therapy does not appear to lower the risk for anogenital cancer among ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A new sequential immunization strategy shows strong promise for an HIV vaccine, a ...

A WhatsApp-based chatbot developed by Nigerian and Swiss researchers has improved practical HIV-related knowledge among people living with HIV in southwestern Nigeria, while earning high trust ratings ...

Gilead's twice-yearly shot reduced HIV infections by 96% in a second large study, the company said. The data sets the stage for likely FDA approval of lenacapavir for HIV prevention. Shares rose 3% in ...

Add Yahoo as a preferred source to see more of our stories on Google. Analysis shows that incidence rates for both males and females showed little or no decrease from 2019 onwards - AFP via Getty ...

OPINION: New tools can transform HIV prevention and treatment. Their reach depends on confronting the barriers that keep people from care.

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...

Young people living with HIV in South Africa achieve high viral suppression rates on long-acting injectable antiretroviral therapy, and all who finished the study chose to continue treatment.

In the early decades of the global response to HIV/AIDS, the focus was on saving lives. And rightly so: without antiretroviral treatment (ART), people lived less than a year, on average, from the time ...